However, neither the actual mechanisms by which chemotherapy triggered the IFN/STAT1 pathway in these breast cancer PDXs nor the actual contribution of the ISG fingerprint to the tumor response were elucidated. The gene discussed is IFNA1; the disease is neoplasm.